Evaluation of degarelix in the management of prostate cancer
Hendrik Van PoppelDepartment of Urology, University Hospitals Leuven, Campus Gasthuisberg, Leuven, BelgiumAbstract: Medical castration using gonadotropin-releasing hormone (GnRH) receptor agonists currently provides the mainstay of androgen deprivation therapy for prostate cancer. Although effective...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-01-01
|
| Series: | Cancer Management and Research |
| Online Access: | http://www.dovepress.com/evaluation-of-degarelix-in-the-management-of-prostate-cancer-a3925 |